ARCHIVES

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities.

May 10, 2002

In Brief: Capp Heads Roentgen Ray Society; Annual Lecture, Chair Honors Charles Spurr

June 22, 1990

Phase III Vaccine Trial Fails To Improve Overall Survival

October 25, 2013

NCI Expected of Fund Cancer Education Grants In Fiscal 1986; Final Fate to Be Decided This Week

March 7, 1986

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

Cancer Meetings Listed

April 18, 1997